Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Ioannis Mykoniatis, Stavros Tsiakaras, Michael Samarinas, Anastasios Anastasiadis, Evangelos N Symeonidis & Petros Sountoulides. (2022) Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis. Biologics: Targets and Therapy 16, pages 47-55.
Read now
Read now
Joseph V. Pergolizzi$suffix/text()$suffix/text(), Giustino Varrassi, Peter Magnusson, Frank Breve, Robert B. Raffa, Paul J. Christo, Maninder Chopra, Antonella Paladini, Jo Ann LeQuang, Kailyn Mitchell & Flaminia Coluzzi. (2022) Pharmacologic agents directed at the treatment of pain associated with maladaptive neuronal plasticity. Expert Opinion on Pharmacotherapy 23:1, pages 105-116.
Read now
Read now
Philip A Barker, Patrick Mantyh, Lars Arendt-Nielsen, Lars Viktrup & Leslie Tive. (2020) Nerve Growth Factor Signaling and Its Contribution to Pain. Journal of Pain Research 13, pages 1223-1241.
Read now
Read now
Falin Patel, Demere K. Hess & Dermot P. Maher. (2020) Anti-nerve growth factor antibodies for the treatment of low back pain. Expert Review of Clinical Pharmacology 13:6, pages 631-639.
Read now
Read now
Kathleen M. Kelly, Panna Sanga, Naim Zaki, Steven Wang, Juergen Haeussler, John Louie & John Thipphawong. (2019) Safety and efficacy of fulranumab in osteoarthritis of the hip and knee: results from four early terminated phase III randomized studies. Current Medical Research and Opinion 35:12, pages 2117-2127.
Read now
Read now
Xiushuai Shang, Zhaofei Wang & Hairong Tao. (2017) Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis pain. Therapeutics and Clinical Risk Management 13, pages 951-956.
Read now
Read now
Justin J. Bailey, Ralf Schirrmacher, Kristen Farrell & Vadim Bernard-Gauthier. (2017) Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 – Part II. Expert Opinion on Therapeutic Patents 27:7, pages 831-849.
Read now
Read now
Articles from other publishers (23)
A. V. Lutsenko & L. V. Saroyants. (2023) The role of nerve growth factor (NGF) in the pathogenesis of leprosy. Medical Herald of the South of Russia 14:1, pages 119-124.
Crossref
Crossref
Tingting Ma, Bei Cao, Lei Huang, Yuanxun Yang, Yan Geng, Pinhao Xie, Yu Zhao, Hui Lin, Kun Wang, Chunhe Wang, Runbin Sun & Juan Li. (2022) First-in-human study to assess the safety, tolerability, pharmacokinetics and immunogenicity of DS002, an anti-nerve growth factor monoclonal antibody. Frontiers in Pharmacology 13.
Crossref
Crossref
Conny Mosley, Tara Edwards, Laura Romano, Geoffrey Truchetti, Laurie Dunbar, Teresa Schiller, Tom Gibson, Charles Bruce & Eric Troncy. (2022) Proposed Canadian Consensus Guidelines on Osteoarthritis Treatment Based on OA-COAST Stages 1–4. Frontiers in Veterinary Science 9.
Crossref
Crossref
Zunaira Qureshi, Murtaza Najabat Ali & Minahil Khalid. (2022) An Insight into Potential Pharmacotherapeutic Agents for Painful Diabetic Neuropathy. Journal of Diabetes Research 2022, pages 1-19.
Crossref
Crossref
Shereen R. Kamel, Radwa S. Ibrahim, Hend M. Moens & Rania M. Mohammed. (2021) Neuropathic pain in primary knee osteoarthritis patients: correlation with physical function, quality of life, disease severity, and serum beta nerve growth factor levels. Egyptian Rheumatology and Rehabilitation 48:1.
Crossref
Crossref
Ziqin Cao, Qiangxiang Li, Jia Guo, Yajia Li & Jianhuang Wu. (2021) Is Targeting Nerve Growth Factor Antagonist a New Option for Pharmacologic Treatment of Low Back Pain? A Supplemental Network Meta-Analysis of the American College of Physicians Guidelines. Frontiers in Pharmacology 12.
Crossref
Crossref
Vui King Vincent-Chong & Mukund Seshadri. (2021) Adrenergic-Angiogenic Crosstalk in Head and Neck Cancer: Mechanisms and Therapeutic Implications. Frontiers in Oral Health 2.
Crossref
Crossref
Jazlyn P. Borges, Katrina Mekhail, Gregory D. Fairn, Costin N. Antonescu & Benjamin E. Steinberg. (2021) Modulation of Pathological Pain by Epidermal Growth Factor Receptor. Frontiers in Pharmacology 12.
Crossref
Crossref
Jinsha Liu, Joey Paolo Ting, Shams Al-Azzam, Yun Ding & Sepideh Afshar. (2021) Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases. International Journal of Molecular Sciences 22:6, pages 2805.
Crossref
Crossref
Huaishuang Shen, Aysha M. Gardner, Juhee Vyas, Ryosuke Ishida & Vivianne L. Tawfik. (2021) Modeling Complex Orthopedic Trauma in Rodents: Bone, Muscle and Nerve Injury and Healing. Frontiers in Pharmacology 11.
Crossref
Crossref
Rodrigo R N Rizzo, Michael C Ferraro, Michael A Wewege, Aidan G Cashin, Hayley B Leake, Edel T O’Hagan, Matthew D Jones, Sylvia M Gustin & James H McAuley. (2021) Efficacy and Safety of Medicines Targeting Neurotrophic Factors in the Management of Low Back Pain: Protocol for a Systematic Review and Meta-analysis. JMIR Research Protocols 10:1, pages e22905.
Crossref
Crossref
Sumonto Mitra, Ruchi Gera, Bengt Linderoth, Göran Lind, Lars Wahlberg, Per Almqvist, Homira Behbahani & Maria Eriksdotter. 2021. Recent Advances in NGF and Related Molecules. Recent Advances in NGF and Related Molecules
167
191
.
Cosmin I. Ciotu & Michael J. M. Fischer. (2020) Novel Analgesics with Peripheral Targets. Neurotherapeutics 17:3, pages 784-825.
Crossref
Crossref
Si Yang, Yu Huang, Ziqi Ye, Lu Li & Yu Zhang. (2020) The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-Analysis. Frontiers in Pharmacology 11.
Crossref
Crossref
Charan Thej & Pawan Kumar Gupta. 2020. Update on Mesenchymal and Induced Pluripotent Stem Cells. Update on Mesenchymal and Induced Pluripotent Stem Cells.
Rashad Farhad ogly Sholan. (2019) The level of nerve growth factor and its relationship with the content of leukocytes and mast cells in experimental interstitial cystitis/painful bladder syndrome. Urologicheskie vedomosti 9:3, pages 5-11.
Crossref
Crossref
Robert M. Leon, Divya Ravi, Jennifer S. An, Carmen L. del Genio, Arnold L. Rheingold, Arti B. Gaur & Glenn C. Micalizio. (2019) Synthesis of C14-Desmethylene Corialactone D and Discovery of Inhibitors of Nerve Growth Factor Mediated Neurite Outgrowth. Organic Letters 21:9, pages 3193-3197.
Crossref
Crossref
Kristina Neugebauer, Christine Hammans, Tobias Wensing, Vinod Kumar, Wolfgang Grodd, Lea Mevissen, Melanie A. Sternkopf, Ana Novakovic, Ted Abel, Ute Habel & Thomas Nickl-Jockschat. (2019) Nerve Growth Factor Serum Levels Are Associated With Regional Gray Matter Volume Differences in Schizophrenia Patients. Frontiers in Psychiatry 10.
Crossref
Crossref
Fangfang Gao, Nathan Griffin, Sam Faulkner, Christopher W. Rowe, Lily Williams, Severine Roselli, Rick F. Thorne, Aysha Ferdoushi, Phillip Jobling, Marjorie M. Walker & Hubert Hondermarck. (2018) The neurotrophic tyrosine kinase receptor TrkA and its ligand NGF are increased in squamous cell carcinomas of the lung. Scientific Reports 8:1.
Crossref
Crossref
Tinara Leila de Souza Aarão, Jorge Rodrigues de Sousa, Aline Semblano Carreira Falcão, Luiz Fábio Magno Falcão & Juarez Antônio Simões Quaresma. (2018) Nerve Growth Factor and Pathogenesis of Leprosy: Review and Update. Frontiers in Immunology 9.
Crossref
Crossref
Alan David Kaye, Elyse M. Cornett, Brendon Hart, Shilpadevi Patil, Andrew Pham, Matthew Spalitta & Kenneth F. Mancuso. (2018) Novel Pharmacological Nonopioid Therapies in Chronic Pain. Current Pain and Headache Reports 22:4.
Crossref
Crossref
Jason J. Ivanusic. (2017) Molecular Mechanisms That Contribute to Bone Marrow Pain. Frontiers in Neurology 8.
Crossref
Crossref
Marcin Chwistek. (2017) Recent advances in understanding and managing cancer pain. F1000Research 6, pages 945.
Crossref
Crossref